Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
5.93M
-
Shares change
-
+672K
-
Total reported value, excl. options
-
$15.2M
-
Value change
-
+$1.73M
-
Number of buys
-
22
-
Number of sells
-
-16
-
Price
-
$2.57
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2024
62 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q2 2024.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.93M shares
of 41M outstanding shares and own 14.47% of the company stock.
Largest 10 shareholders include Murchinson Ltd. (1.7M shares), BML Capital Management, LLC (1.35M shares), BOOTHBAY FUND MANAGEMENT, LLC (825K shares), Rathbones Group PLC (290K shares), TWO SIGMA ADVISERS, LP (259K shares), RENAISSANCE TECHNOLOGIES LLC (231K shares), BANK OF AMERICA CORP /DE/ (173K shares), TWO SIGMA INVESTMENTS, LP (150K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (126K shares), and BlackRock Inc. (89.7K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.